L3VLUP
ProSign in

BEAM · ARGX in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BEAMARGX
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BEAM
  • ARGX
0102030202120222023202420252026
Holders and value by quarter
QuarterBEAMARGX
Q3 2020none listed holders, n.a.8 holders, $3.6bn
Q4 20204 holders, $705m7 holders, $4.1bn
Q1 20216 holders, $1.1bn8 holders, $4.1bn
Q2 20216 holders, $2.1bn9 holders, $4.6bn
Q3 20215 holders, $769m8 holders, $4.5bn
Q4 20213 holders, $818m9 holders, $5.3bn
Q1 20224 holders, $620m8 holders, $5.3bn
Q2 20224 holders, $457m13 holders, $6.5bn
Q3 20225 holders, $610m14 holders, $5.3bn
Q4 20224 holders, $481m13 holders, $5.5bn
Q1 20234 holders, $397m13 holders, $5.9bn
Q2 20233 holders, $394m18 holders, $6.6bn
Q3 20234 holders, $351m21 holders, $8.7bn
Q4 20234 holders, $389m17 holders, $6.3bn
Q1 20244 holders, $446m13 holders, $6.8bn
Q2 20243 holders, $379m14 holders, $7.9bn
Q3 20243 holders, $370m13 holders, $10.7bn
Q4 20244 holders, $394m14 holders, $12.3bn
Q1 20255 holders, $419m17 holders, $11.8bn
Q2 20255 holders, $358m18 holders, $10.8bn
Q3 20257 holders, $571m16 holders, $13.8bn
Q4 20256 holders, $692m16 holders, $14.8bn
Q1 20263 holders, $540m11 holders, $12.3bn
Q2 20263 holders, $713m14 holders, $15.0bn
BEAM

Beam Therapeutics Inc

Holders
4
Reported value
$394m
Buyers
3
Sellers
1

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
ARGX

Argenx Se

Holders
14
Reported value
$12.3bn
Buyers
8
Sellers
6

Breadth +2 among 94 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q4 2024

Among the 17 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only BEAM (3)

ARK Investment Management LLC, Baillie Gifford & Co, Farallon Capital Management LLC

Only ARGX (13)

Artisan Partners LP, Capital World Investors, Citadel Advisors LLC, D. E. Shaw & Co., Fidelity (FMR LLC), Holocene Advisors LP, Janus Henderson Group Ltd, Marshall Wace LLP, Moore Capital Management LP, Point72 Asset Management LP, T. Rowe Price Associates Inc, Voloridge Investment Management LLC, Wellington Management Group LLP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →